User menu

2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection.

Bibliographic reference Demetris, A J ; Bellamy, C ; Hübscher, S G ; O'Leary, J ; Randhawa, P S ; et. al. 2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection.. In: American Journal of Transplantation, Vol. 16, no.10, p. 2816-2835 (2016)
Permanent URL http://hdl.handle.net/2078.1/184132
  1. , Demetris Anthony, Importance of liver biopsy findings in immunosuppression management: Biopsy monitoring and working criteria for patients with operational tolerance, 10.1002/lt.23481
  2. , Banff schema for grading liver allograft rejection: An international consensus document, 10.1002/hep.510250328
  3. , Update of the International Banff Schema for liver allograft rejection: Working recommendations for the histopathologic staging and reporting of chronic rejection, 10.1002/hep.510310337
  4. Stewart Susan, Fishbein Michael C., Snell Gregory I., Berry Gerald J., Boehler Annette, Burke Margaret M., Glanville Alan, Gould F. Kate, Magro Cynthia, Marboe Charles C., McNeil Keith D., Reed Elaine F., Reinsmoen Nancy L., Scott John P., Studer Sean M., Tazelaar Henry D., Wallwork John L., Westall Glen, Zamora Martin R., Zeevi Adriana, Yousem Samuel A., Revision of the 1996 Working Formulation for the Standardization of Nomenclature in the Diagnosis of Lung Rejection, 10.1016/j.healun.2007.10.017
  5. Mengel M., Sis B., Haas M., Colvin R. B., Halloran P. F., Racusen L. C., Solez K., Cendales L., Demetris A. J., Drachenberg C. B., Farver C. F., Rodriguez E. R., Wallace W. D., Glotz D., , Banff 2011 Meeting Report: New Concepts in Antibody-Mediated Rejection : 2011 Banff Meeting, 10.1111/j.1600-6143.2011.03926.x
  6. Haas M., Sis B., Racusen L. C., Solez K., Glotz D., Colvin R. B., Castro M. C. R., David D. S. R., David-Neto E., Bagnasco S. M., Cendales L. C., Cornell L. D., Demetris A. J., Drachenberg C. B., Farver C. F., Farris A. B., Gibson I. W., Kraus E., Liapis H., Loupy A., Nickeleit V., Randhawa P., Rodriguez E. R., Rush D., Smith R. N., Tan C. D., Wallace W. D., Mengel M., , Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions : Banff 2013 Meeting Report, 10.1111/ajt.12590
  7. Berry Gerald J., Burke Margaret M., Andersen Claus, Bruneval Patrick, Fedrigo Marny, Fishbein Michael C., Goddard Martin, Hammond Elizabeth H., Leone Ornella, Marboe Charles, Miller Dylan, Neil Desley, Rassl Doris, Revelo Monica P., Rice Alexandra, Rene Rodriguez E., Stewart Susan, Tan Carmela D., Winters Gayle L., West Lori, Mehra Mandeep R., Angelini Annalisa, The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation, 10.1016/j.healun.2013.08.011
  8. Drachenberg C. B., Odorico J., Demetris A.J., Arend L., Bajema I. M., Bruijn J. A., Cantarovich D., Cathro H. P., Chapman J., Dimosthenous K., Fyfe-Kirschner B., Gaber L., Gaber O., Goldberg J., Honsová E., Iskandar S. S., Klassen D. K., Nankivell B., Papadimitriou J. C., Racusen L. C., Randhawa P., Reinholt F. P., Renaudin K., Revelo P. P., Ruiz P., Torrealba J. R., Vazquez-Martul E., Voska L., Stratta R., Bartlett S. T., Sutherland D. E. R., Banff Schema for Grading Pancreas Allograft Rejection: Working Proposal by a Multi-Disciplinary International Consensus Panel, 10.1111/j.1600-6143.2008.02212.x
  9. Sánchez–Fueyo Alberto, Strom Terry B., Immunologic Basis of Graft Rejection and Tolerance Following Transplantation of Liver or Other Solid Organs, 10.1053/j.gastro.2010.10.059
  10. , Demetris A. J., Liver biopsy interpretation for causes of late liver allograft dysfunction, 10.1002/hep.21280
  11. Evans Helen M., Kelly Deirdre A., McKiernan Patrick J., Hübscher Stefan, Progressive histological damage in liver allografts following pediatric liver transplantation, 10.1002/hep.21152
  12. Li Xue, Sun Qiquan, Zhang Mingchao, Xie Kenan, Chen Jinsong, Liu Zhihong, Capillary Dilation and Rarefaction Are Correlated with Intracapillary Inflammation in Antibody-Mediated Rejection, 10.1155/2014/582902
  13. Escaned J., Flores A., Garcia-Pavia P., Segovia J., Jimenez J., Aragoncillo P., Salas C., Alfonso F., Hernandez R., Angiolillo D. J., Jimenez-Quevedo P., Banuelos C., Alonso-Pulpon L., Macaya C., Assessment of Microcirculatory Remodeling With Intracoronary Flow Velocity and Pressure Measurements: Validation With Endomyocardial Sampling in Cardiac Allografts, 10.1161/circulationaha.108.834739
  14. Drachenberg Cinthia B., Papadimitriou John C., Endothelial Injury in Renal Antibody-Mediated Allograft Rejection : A Schematic View Based on Pathogenesis, 10.1097/tp.0b013e31827e6b45
  15. Valenzuela Nicole M., McNamara Jeffrey T., Reed Elaine F., Antibody-mediated graft injury : complement-dependent and complement-independent mechanisms, 10.1097/mot.0000000000000040
  16. Valenzuela Nicole M., Reed Elaine F., Antibodies in Transplantation: The Effects of HLA and Non-HLA Antibody Binding and Mechanisms of Injury, Methods in Molecular Biology (2013) ISBN:9781627034920 p.41-70, 10.1007/978-1-62703-493-7_2
  17. Djamali A., Kaufman D. B., Ellis T. M., Zhong W., Matas A., Samaniego M., Diagnosis and Management of Antibody-Mediated Rejection: Current Status and Novel Approaches : Current Status of Antibody-Mediated Rejection, 10.1111/ajt.12589
  18. Farkash Evan A., Colvin Robert B., Pathology: Diagnostic challenges in chronic antibody-mediated rejection, 10.1038/nrneph.2012.61
  19. de Kort Hanneke, Roufosse Candice, Bajema Ingeborg M., Drachenberg Cinthia B., Pancreas transplantation, antibodies and rejection : where do we stand?, 10.1097/mot.0b013e3283614a5c
  20. Demetris A., Murase N., Nakamura K., Iwaki Y., Yagihashi A., Valdivia L., Todo S., Iwatsuki S., Takaya S., Fung J., Starzl T., Immunopathology of Antibodies as Effectors of Orthotopic Liver Allograft Rejection, 10.1055/s-2007-1007376
  21. Demetris Anthony J., Zeevi Adriana, O’Leary Jacqueline G., ABO-compatible liver allograft antibody-mediated rejection : an update, 10.1097/mot.0000000000000194
  22. O'Leary J. G., Demetris A. J., Friedman L. S., Gebel H. M., Halloran P. F., Kirk A. D., Knechtle S. J., McDiarmid S. V., Shaked A., Terasaki P. I., Tinckam K. J., Tomlanovich S. J., Wood K. J., Woodle E. S., Zachary A. A., Klintmalm G. B., The Role of Donor-Specific HLA Alloantibodies in Liver Transplantation : DSA in Liver Transplantation, 10.1111/ajt.12667
  23. Netto, Arch Pathol Lab Med, 130, 1157 (2006)
  24. Demetris A. J., Ruppert K., Dvorchik I., Jain A., Minervini M., Nalesnik M. A., Randhawa P., Wu T., Zeevi A., Abu-Elmagd K., Eghtesad B., Fontes P., Cacciarelli T., Marsh W., Geller D., Fung J. J., Real-time monitoring of acute liver-allograft rejection using the Banff schema1 : , 10.1097/00007890-200211150-00016
  25. Sebagh M, Accuracy of bile duct changes for the diagnosis of chronic liver allograft rejection: Reliability of the 1999 Banff schema, 10.1053/jhep.2002.30085
  26. Höroldt Barbara S., Burattin Marco, Gunson Bridget K., Bramhall Simon R., Nightingale Peter, Hübscher Stefan G., Neuberger James M., Does the Banff rejection activity index predict outcome in patients with early acute cellular rejection following liver transplantation?, 10.1002/lt.20779
  27. Ormonde Donald G., de Boer W. Bastiaan, Kierath Anthony, Bell Roger, Shilkin Keith B., House Anthony K., Jeffrey Gary P., Reed William D., Banff schema for grading liver allograft rejection: Utility in clinical practice, 10.1002/lt.500050418
  28. Abraham Susan C., Freese Deborah K., Ishitani Michael B., Krasinskas Alyssa M., Wu Tsung-Teh, Significance of Central Perivenulitis in Pediatric Liver Transplantation : , 10.1097/pas.0b013e31817a8e96
  29. Khettry Urmila, Backer Amy, Ayata Gamze, Lewis W.David, Jenkins Roger L., Gordon Fredric D., Centrilobular histopathologic changes in liver transplant biopsies, 10.1053/hupa.2002.32225
  30. Sanei Mohammad Hossein, Schiano Thomas D., Sempoux Christine, Fan Cathy, Fiel M. Isabel, Acute Cellular Rejection Resulting in Sinusoidal Obstruction Syndrome and Ascites Postliver Transplantation : , 10.1097/tp.0b013e318234119d
  31. Yamada Hiroyuki, Kondou Hiroki, Kimura Takeshi, Ikeda Kayo, Tachibana Makiko, Hasegawa Yasuhiro, Kiyohara Yuki, Ueno Takehisa, Miyoshi Yoko, Mushiake Sotaro, Ozono Keiichi, Humoral immunity is involved in the development of pericentral fibrosis after pediatric live donor liver transplantation : Pericentral fibrosis and humoral immunity, 10.1111/j.1399-3046.2012.01781.x
  32. Venturi C., Sempoux C., Bueno J., Ferreres Pinas J. C., Bourdeaux C., Abarca-Quinones J., Rahier J., Reding R., Novel Histologic Scoring System for Long-Term Allograft Fibrosis After Liver Transplantation in Children : Scoring for Liver Allograft Fibrosis, 10.1111/j.1600-6143.2012.04210.x
  33. Sebagh Mylène, Castillo-Rama Marcela, Azoulay Daniel, Coilly Audrey, Delvart Valérie, Allard Marc-Antoine, Dos Santos Alexandre, Johanet Catherine, Roque-Afonso Anne-Marie, Saliba Faouzi, Duclos-Vallée Jean-Charles, Samuel Didier, Demetris Anthony Jack, Histologic Findings Predictive of a Diagnosis of De novo Autoimmune Hepatitis After Liver Transplantation in Adults : , 10.1097/tp.0b013e31829eda7f
  34. Castillo-Rama M., Sebagh M., Sasatomi E., Randhawa P., Isse K., Salgarkar A. D., Ruppert K., Humar A., Demetris A. J., “Plasma Cell Hepatitis” in Liver Allografts: Identification and Characterization of an IgG4-Rich Cohort : IgG4-Rich Cohort in Plasma Cell Hepatitis, 10.1111/ajt.12413
  35. Fiel M. Isabel, Schiano Thomas D., Plasma cell hepatitis (de-novo autoimmune hepatitis) developing post liver transplantation : , 10.1097/mot.0b013e3283536622
  36. Levitsky Josh, Fiel Maria Isabel, Norvell John P., Wang Edward, Watt Kymberly D., Curry Michael P., Tewani Sumeet, McCashland Timothy M., Hoteit Maarouf A., Shaked Abraham, Saab Samuel, Chi Amanda C., Tien Amy, Schiano Thomas D., Risk for Immune-Mediated Graft Dysfunction in Liver Transplant Recipients With Recurrent HCV Infection Treated With Pegylated Interferon, 10.1053/j.gastro.2012.01.030
  37. Demetris Anthony J., Sebagh Mylene, Plasma cell hepatitis in liver allografts: Variant of rejection or autoimmune hepatitis?, 10.1002/lt.21518
  38. Fiel M. Isabel, Agarwal Kaushik, Stanca Carmen, Elhajj Nassim, Kontorinis Nikolas, Thung Swan N., Schiano Thomas D., Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus, 10.1002/lt.21447
  39. Kerkar Nanda, Hadzic Nedim, Davies Edward T, Portmann Bernard, Donaldson Peter T, Rela Mohamed, Heaton Nigel D, Vergani Diego, Mieli-Vergani Giorgina, De-novo autoimmune hepatitis after liver transplantation, 10.1016/s0140-6736(97)06478-7
  40. Ward Stephen C., Schiano Thomas D., Thung Swan N., Fiel M. Isabel, Plasma cell hepatitis in hepatitis C virus patients post–liver transplantation: Case-control study showing poor outcome and predictive features in the liver explant, 10.1002/lt.21949
  41. Wozniak Laura J., Hickey Michelle J., Venick Robert S., Vargas Jorge H., Farmer Douglas G., Busuttil Ronald W., McDiarmid Sue V., Reed Elaine F., Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation : , 10.1097/tp.0000000000000796
  42. Umemura Takeji, Zen Yoh, Hamano Hideaki, Joshita Satoru, Ichijo Tetsuya, Yoshizawa Kaname, Kiyosawa Kendo, Ota Masao, Kawa Shigeyuki, Nakanuma Yasuni, Tanaka Eiji, Clinical significance of immunoglobulin G4-associated autoimmune hepatitis, 10.1007/s00535-010-0323-4
  43. Salcedo M, Response to steroids in de novo autoimmune hepatitis after liver transplantation, 10.1053/jhep.2002.31167
  44. Aguilera Isabel, Sousa Jose M., Gavilán Francisco, Bernardos Angel, Wichmann Ingeborg, Nuñez-Roldán Antonio, Glutathione S-transferase T1 mismatch constitutes a risk factor forde novoimmune hepatitis after liver transplantation : GSTT1 Mismatch and Posttransplant Hepatitis, 10.1002/lt.20209
  45. Pongpaibul Ananya, Venick Robert S., McDiarmid Sue V., Lassman Charles R., Histopathology of de novo autoimmune hepatitis, 10.1002/lt.23422
  46. Trivedi, Hepatology, 457A (2014)
  47. Aguilera Isabel, Sousa José Manuel, Gavilan Francisco, Gomez Lourdes, Álvarez-Márquez Antonia, Núñez-Roldán Antonio, Complement component 4d immunostaining in liver allografts of patients with de novo immune hepatitis, 10.1002/lt.22302
  48. Aguilera I., Wichmann I., Sousa J. M., Bernardos A., Franco E., García-Lozano J. R., Núñez-Roldán A., Antibodies against glutathione S-transferase T1 (GSTT1) in patients withde novoimmune hepatitis following liver transplantation, 10.1046/j.1365-2249.2001.01682.x
  49. Venick R. S., McDiarmid S. V., Farmer D. G., Gornbein J., Martin M. G., Vargas J.H., Ament M. E., Busuttil R. W., Rejection and Steroid Dependence: Unique Risk Factors in the Development of Pediatric Posttransplant De Novo Autoimmune Hepatitis, 10.1111/j.1600-6143.2006.01717.x
  50. Mendes Flavia, Couto Claudia A., Levy Cynthia, Recurrent and De Novo Autoimmune Liver Diseases, 10.1016/j.cld.2011.08.008
  51. Czaja Albert J., Manns Michael P., Advances in the Diagnosis, Pathogenesis, and Management of Autoimmune Hepatitis, 10.1053/j.gastro.2010.04.053
  52. Hübscher Stefan G., What is the long-term outcome of the liver allograft?, 10.1016/j.jhep.2011.03.005
  53. Inui Ayano, Sogo Tsuyoshi, Komatsu Haruki, Miyakawa Hiroshi, Fujisawa Tomoo, Antibodies against cytokeratin 8/18 in a patient with de novo autoimmune hepatitis after living-donor liver transplantation, 10.1002/lt.20404
  54. HUGUET S., VINH J., JOHANET C., SAMUEL D., GIGOU M., ZAMFIR O., DUCLOS-VALLEE J.-C., BALLOT E., Identification by Proteomic Tool of Atypical Anti-Liver/Kidney Microsome Autoantibodies Targets in de Novo Autoimmune Hepatitis after Liver Transplantation, 10.1196/annals.1398.041
  55. Ohe Hidenori, Uchida Yoichiro, Yoshizawa Atsushi, Hirao Hirofumi, Taniguchi Michiko, Maruya Etsuko, Yurugi Kimiko, Hishida Rie, Maekawa Taira, Uemoto Shinji, Terasaki Paul I., Association of Anti-Human Leukocyte Antigen and Anti-Angiotensin II Type 1 Receptor Antibodies With Liver Allograft Fibrosis After Immunosuppression Withdrawal : , 10.1097/tp.0000000000000185
  56. Kerkar Nanda, Yanni George, ‘De novo’ and ‘recurrent’ autoimmune hepatitis after liver transplantation: A comprehensive review, 10.1016/j.jaut.2015.08.017
  57. Demetris, Am J Pathol, 132, 489 (1988)
  58. Gordon, Surgery, 100, 342 (1986)
  59. Rego, Transplant Proc, 19, 4589 (1987)
  60. Gugenheim, Transplant Proc, 21, 2223 (1989)
  61. Sanchez-Urdazpal, Transplant Proc, 23, 1440 (1991)
  62. Doyle Howard R., Marino Ignazio R., Morelli Franca, Doria Cataldo, Aldrighetti Luca, McMichael John, Martell Joan, Gayowski Timothy, Starzl Thomas E., Assessing Risk in Liver Transplantation : Special Reference to the Significance of a Positive Cytotoxic Crossmatch, 10.1097/00000658-199608000-00009
  63. Karuppan S., Ericzon B. G., Möller E-, Relevance of a positive crossmatch in liver transplantation, 10.1111/j.1432-2277.1991.tb01940.x
  64. TAKAYA SHUNICHI, BRONSTHER OSCAR, IWAKI YUICHI, NAKAMURA KENJIRO, ABU-ELMAGD KAREEM, YAGIHASHI ATSUHITO, DEMETRIS A. JAKE, KOBAYASHI MAKOTO, TODO SATORU, TZAKIS ANDREAS G., FUNG JOHN J., STARZL THOMAS E., THE ADVERSE IMPACT ON LIVER TRANSPLANTATION OF USING POSITIVE CYTOTOXIC CROSSMATCH DONORS 1, 2 : , 10.1097/00007890-199202010-00026
  65. Nikaein Afzal, Backman Lars, Jennings Linda, Levy Marlon F., Goldstein Robert, Gonwa Thomas, Stone Marvin J., Klintmal Goran, HLA COMPATIBILITY AND LIVER TRANSPLANT OUTCOME Improved Patient Survival by HLA and Cross-Matching : , 10.1097/00007890-199410150-00006
  66. Bathgate Andrew J., McColl Mary, Garden O. James, Forsythe John L., Madhavan Krishna K., Hayes Peter C., The effect of a positive T-lymphocytotoxic crossmatch on hepatic allograft survival and rejection, 10.1002/lt.500040411
  67. Andres G.A., Ansell I.D., Halgrimson C.G., Hsu K.C., Porter K.A., Starzl T.E., Accinni L., Calne R.Y., Herbertson B.M., Penn I., Rendall J.M., Williams R., IMMUNOPATHOLOGICAL STUDIES OF ORTHOTOPIC HUMAN LIVER ALLOGRAFTS, 10.1016/s0140-6736(72)90288-7
  68. Gugenheim Jean, Charpentier Bernard, Gigou Michelle, Cuomo Oreste, Calise Fulvio, Amorosa Luigi, Astarcioglu Ibraim, Folch Manuel Trias I, Martin Bernadette, Bismuth Henri, DELAYED REJECTION OF HEART ALLOGRAFTS AFTER EXTRACORPOREAL DONOR-SPECIFIC LIVER HEMOPERFUSION : , 10.1097/00007890-198803000-00025
  69. GUGENHEIM JEAN, AMOROSA LUIGI, GIGOU MICHELLE, FABIANI BETTINA, ROUGER PHILIPPE, GANE PIERRE, REYNES MICHEL, BISMUTH HENIR, SPECIFIC ABSORPTION OF LYMPHOCYTOTOXIC ALLOANTIBODIES BY THE LIVER IN INBRED RATS : , 10.1097/00007890-199008000-00027
  70. Saidman Susan L., Duquesnoy Rene J., Demetris A.Jake, McCauley Jerry, Ramos Hector, Mazariegos George, Shapiro Ron, Starzl Thomas E., Fung John J., Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies, 10.1016/0966-3274(94)90080-9
  71. Eid, Transplantation, 50, 331 (1990)
  72. Olausson M., Mjörnstedt L., Nordén G., Rydberg L., Mölne J., Bäckman L., Friman S., Successful Combined Partial Auxiliary Liver and Kidney Transplantation in Highly Sensitized Cross-Match Positive Recipients, 10.1111/j.1600-6143.2006.01592.x
  73. Hubscher, Curr Opin Organ Transplant, 17, 280 (2012)
  74. Nakamura, Am J Pathol, 142, 1383 (1993)
  75. &NA;, SPONTANEOUS LONG-TERM SURVIVAL OF LIVER ALLOGRAFTS IN INBRED RATS Influence of the Hepatectomy of the Recipientʼs Own Liver : , 10.1097/00007890-198111000-00022
  76. Gugenheim J., Thai B. Le, Rouger P., Gigou M., Gane P., Vial M. C., Charpentier B., Reynes M., Bismuth H., RELATIONSHIP BETWEEN THE LIVER AND LYMPHOCYTOTOXIC ALLOANTIBODIES IN INBRED RATS : Specific Absorption by Nonparenchymal Liver Cells, 10.1097/00007890-198802000-00046
  77. Astarcioglu Ibraõm, Cursio Raffaele, Reynes Michel, Gugenheim Jean, Increased Risk of Antibody-Mediated Rejection of Reduced-Size Liver Allografts, 10.1006/jsre.1999.5734
  78. Geissler Edward K., Graeb Christian, Tange Stefan, Guba Marcus, Jauch Karl-Walter, Scherer Marcus N., Effective Use of Donor MHC Class I Gene Therapy in Organ Transplantation: Prevention of Antibody-Mediated Hyperacute Heart Allograft Rejection in Highly Sensitized Rat Recipients, 10.1089/10430340050015923
  79. Demetris Anthony J., Isse Kumiko, Tissue biopsy monitoring of operational tolerance in liver allograft recipients : , 10.1097/mot.0b013e3283615d48
  80. Muczynski K. A., Normal Human Kidney HLA-DR-Expressing Renal Microvascular Endothelial Cells: Characterization, Isolation, and Regulation of MHC Class II Expression, 10.1097/01.asn.0000061778.08085.9f
  81. Page, Am J Pathol, 141, 673 (1992)
  82. Dar W., Agarwal A., Watkins C., Gebel H. M., Bray R. A., Kokko K. E., Pearson T. C., Knechtle S. J., Donor-Directed MHC Class I Antibody Is Preferentially Cleared from Sensitized Recipients of Combined Liver/Kidney Transplants : Humoral Rejection in Liver Kidney Transplants, 10.1111/j.1600-6143.2011.03467.x
  83. O'Leary Jacqueline G., Kaneku Hugo, Jennings Linda W., Bañuelos Nubia, Susskind Brian M., Terasaki Paul I., Klintmalm Göran B., Preformed class II donor-specific antibodies are associated with an increased risk of early rejection after liver transplantation : Preformed DSAsin Liver Transplantation, 10.1002/lt.23687
  84. DeLeve Laurie D., Liver sinusoidal endothelial cells in hepatic fibrosis : DELEVE, 10.1002/hep.27376
  85. TUIJNMAN WOUTER B., WICHEN DICK F., SCHUURMAN HENK-JAN, Tissue distribution of human IgG Fc receptors CD16, CD32 and CD64: An immunohistochemical study, 10.1111/j.1699-0463.1993.tb00117.x
  86. Demetris A. J., Bellamy C. O. C., Gandhi C. R., Prost S., Nakanuma Y., Stolz D. B., Functional Immune Anatomy of the Liver-As an Allograft, 10.1111/ajt.13749
  87. Liu Xiao, Xu Jun, Brenner David A., Kisseleva Tatiana, Reversibility of Liver Fibrosis and Inactivation of Fibrogenic Myofibroblasts, 10.1007/s40139-013-0018-7
  88. DAAR A. S., FUGGLE S. V., FABRE J. W., TING A., MORRIS P. J., THE DETAILED DISTRIBUTION OF HLA-A, B, C ANTIGENS IN NORMAL HUMAN ORGANS : , 10.1097/00007890-198409000-00018
  89. DAAR A. S., FUGGLE S. V., FABRE J. W., TING A., MORRIS P. J., THE DETAILED DISTRIBUTION OF MHC CLASS II ANTIGENS IN NORMAL HUMAN ORGANS : , 10.1097/00007890-198409000-00019
  90. Lautenschlager Irmeli, Taskinen Eero, Inkinen Kaija, Lehto Veli-Pekka, Virtanen Ismo, Häyry Pekka, Distribution of the major histocompatibility complex antigens on different cellular components of human liver, 10.1016/0008-8749(84)90289-2
  91. DEMETRIS A. JAKE, LASKY STEVEN, VAN THIEL DAVID H., STARZL THOMAS E., WHITESIDE THERESA, INDUCTION OF DR/IA ANTIGENS IN HUMAN LIVER ALLOGRAFTS : AN IMMUNOCYTOCHEMICAL AND CLINICOPATHOLOGIC ANALYSIS OF TWENTY FAILED GRAFTS, 10.1097/00007890-198511000-00007
  92. Ballardini, Clin Exp Immunol, 70, 35 (1987)
  93. Barbatis C, Kelly P, Greveson J, Heryet A, McGee J O, Immunocytochemical analysis of HLA class II (DR) antigens in liver disease in man., 10.1136/jcp.40.8.879
  94. Steinhoff G., Wonigeit K., Pichlmayr R., ANALYSIS OF SEQUENTIAL CHANGES IN MAJOR HISTOCOMPATIBILITY COMPLEX EXPRESSION IN HUMAN LIVER GRAFTS AFTER TRANSPLANTATION : , 10.1097/00007890-198802000-00030
  95. Gouw, Am J Pathol, 133, 82 (1988)
  96. Steinhoff, J Heart Transplant, 8, 360 (1989)
  97. Steinhoff Gustav, Major histocompatibility complex antigens in human liver transplants, 10.1016/0168-8278(90)90264-r
  98. Hubscher S. G., Adams D. H., Elias E., Changes in the expression of major histocompatibility complex class II antigens in liver allograft rejection, 10.1002/path.1711620210
  99. Terada, Clin Exp Immunol, 84, 303 (1991)
  100. Terada, Arch Pathol Lab Med, 115, 993 (1991)
  101. O'Leary J. G., Cai J., Freeman R., Banuelos N., Hart B., Johnson M., Jennings L. W., Kaneku H., Terasaki P. I., Klintmalm G. B., Demetris A. J., Proposed Diagnostic Criteria for Chronic Antibody-Mediated Rejection in Liver Allografts : Chronic AMR in Liver Transplant, 10.1111/ajt.13476
  102. Rockey Don C., Caldwell Stephen H., Goodman Zachary D., Nelson Rendon C., Smith Alastair D., Liver biopsy, 10.1002/hep.22742
  103. Demetris A.J, Ruppert Kris, Pathologist's perspective on liver needle biopsy size?, 10.1016/s0168-8278(03)00282-4
  104. Bellamy C O C, Herriot M M, Harrison D J, Bathgate A J, C4d immunopositivity is uncommon in ABO-compatible liver allografts, but correlates partially with lymphocytotoxic antibody status, 10.1111/j.1365-2559.2007.02677.x
  105. Bellamy Christopher O. C., Complement C4d immunohistochemistry in the assessment of liver allograft biopsy samples: Applications and pitfalls, 10.1002/lt.22323
  106. Cohen Danielle, Colvin Robert B., Daha Mohamed R., Drachenberg Cinthia B., Haas Mark, Nickeleit Volker, Salmon Jane E., Sis Banu, Zhao Ming-Hui, Bruijn Jan A., Bajema Ingeborg M., Pros and cons for C4d as a biomarker, 10.1038/ki.2011.497
  107. Smith R. Neal, Colvin Robert B., Chronic alloantibody mediated rejection, 10.1016/j.smim.2011.09.002
  108. Sapir-Pichhadze Ruth, Curran Simon P., John Rohan, Tricco Andrea C., Uleryk Elizabeth, Laupacis Andreas, Tinckam Kathryn, Sis Banu, Beyene Joseph, Logan Alexander G., Kim S Joseph, A systematic review of the role of C4d in the diagnosis of acute antibody-mediated rejection, 10.1038/ki.2014.166
  109. Miller, Arch Pathol Lab Med, 134, 1679 (2010)
  110. Ludovico-Martins H., Silva C., Teodoro W.R., Martini Filho D., Noronha I.L., Analysis of Different Staining Techniques for C4d Detection in Renal Allograft Biopsies, 10.1016/j.transproceed.2009.01.073
  111. Seemayer C. A., Gaspert A., Nickeleit V., Mihatsch M. J., C4d staining of renal allograft biopsies: a comparative analysis of different staining techniques, 10.1093/ndt/gfl594
  112. Troxell M. L., Comparison of C4d Immunostaining Methods in Renal Allograft Biopsies, 10.2215/cjn.00900805
  113. Nadasdy Gyongyi M., Bott Cherri, Cowden Daniel, Pelletier Ronald, Ferguson Ronald, Nadasdy Tibor, Comparative study for the detection of peritubular capillary C4d deposition in human renal allografts using different methodologies, 10.1016/j.humpath.2005.08.002
  114. Chantranuwat Chavit, Qiao Jian-Hua, Kobashigawa Jon, Hong Longsheng, Shintaku Peter, Fishbein Michael C., Immunoperoxidase Staining for C4d on Paraffin-embedded Tissue in Cardiac Allograft Endomyocardial Biopsies : Comparison to Frozen Tissue Immunofluorescence, 10.1097/00129039-200406000-00012
  115. Bu X., Zheng Z., Yu Y., Zeng L., Jiang Y., Significance of C4d Deposition in the Diagnosis of Rejection After Liver Transplantation, 10.1016/j.transproceed.2006.03.018
  116. Dankof Anja, Schmeding Maximilian, Morawietz Lars, Günther Raphaela, Krukemeyer Manfred G., Rudolph Birgit, Koch Martin, Krenn Veit, Neumann Ulf, Portal capillary C4d deposits and increased infiltration by macrophages indicate humorally mediated mechanisms in acute cellular liver allograft rejection, 10.1007/s00428-005-1245-z
  117. Haga Hironori, Egawa Hiroto, Fujimoto Yasuhiro, Ueda Mikiko, Miyagawa-Hayashino Aya, Sakurai Takaki, Okuno Tomoko, Koyanagi Itsuko, Takada Yasutsugu, Manabe Toshiaki, Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation, 10.1002/lt.20652
  118. Jain Ashok, Ryan Charlotte, Mohanka Ravi, Orloff Mark, Abt Peter, Romano Joan, Bryan Leah, Batzold Pam, Mantry Parvez, Bozorgzadeh Adel, Characterization of CD4, CD8, CD56 positive lymphocytes and C4d deposits to distinguish acute cellular rejection from recurrent hepatitis C in post-liver transplant biopsies, 10.1111/j.1399-0012.2006.00528.x
  119. Krukemeyer Manfred G., Moeller Johannes, Morawietz Lars, Rudolph Birgit, Neumann Ulf, Theruvath Tom, Neuhaus Peter, Krenn Veit, Description of B Lymphocytes and Plasma Cells, Complement, and Chemokines/Receptors in Acute Liver Allograft Rejection : , 10.1097/01.tp.0000132324.14207.8b
  120. Sakashita Hiromi, Haga Hironori, Ashihara Eishi, Wen Mei-Chin, Tsuji Hiroaki, Miyagawa-Hayashino Aya, Egawa Hiroto, Takada Yasutsugu, Maekawa Taira, Uemoto Shinji, Manabe Toshiaki, Significance of C4d staining in ABO-identical/compatible liver transplantation, 10.1038/modpathol.3800784
  121. Sawada Tokihiko, Shimizu Akira, Kubota Keiichi, Fuchinoue Shohei, Teraoka Satoshi, Lobular damage caused by cellular and humoral immunity in liver allograft rejection, 10.1111/j.1399-0012.2004.00310.x
  122. Troxell, Arch Pathol Lab Med, 130, 1489 (2006)
  123. Bouron-Dal Soglio Dorothée, Rougemont Anne-Laure, Herzog Denise, Soucy Geneviève, Alvarez Fernando, Fournet Jean-Christophe, An immunohistochemical evaluation of C4d deposition in pediatric inflammatory liver diseases, 10.1016/j.humpath.2007.12.014
  124. Schmeding M., Dankof A., Krenn V., Krukemeyer M.G., Koch M., Spinelli A., Langrehr J.M., Neumann U.P., Neuhaus P., C4d in Acute Rejection After Liver Transplantation-A Valuable Tool in Differential Diagnosis to Hepatitis C Recurrence : C4d in Acute Rejection After Liver Transplantation, 10.1111/j.1600-6143.2005.01180.x
  125. Silva Michael A., Mirza Darius F., Murphy Nick, Richards Douglas A., Reynolds Gary M., Wigmore Stephen J., Neil Desley A. H., Intrahepatic Complement Activation, Sinusoidal Endothelial Injury, and Lactic Acidosis Are Associated With Initial Poor Function of the Liver After Transplantation : , 10.1097/tp.0b013e3181663366
  126. Taner T., Gandhi M. J., Sanderson S. O., Poterucha C. R., De Goey S. R., Stegall M. D., Heimbach J. K., Prevalence, Course and Impact of HLA Donor-Specific Antibodies in Liver Transplantation in the First Year : DSA in Liver Transplantation, 10.1111/j.1600-6143.2012.03995.x
  127. O'Leary Jacqueline G., Kaneku Hugo, Jennings Linda, Susskind Brian M., Terasaki Paul I., Klintmalm Göran B., Donor-specific alloantibodies are associated with fibrosis progression after liver transplantation in hepatitis C virus-infected patients : Donor-Specific Antibodies and Fibrosis Progression, 10.1002/lt.23854
  128. Kozlowski Tomasz, Rubinas Tara, Nickeleit Volker, Woosley John, Schmitz John, Collins Dana, Hayashi Paul, Passannante Anthony, Andreoni Kenneth, Liver allograft antibody-mediated rejection with demonstration of sinusoidal C4d staining and circulating donor-specific antibodies, 10.1002/lt.22233
  129. Demetris Anthony J., Nakamura Kenjiro, Yagihashi Atsuhito, Iwaki Yuichi, Takaya Shunichi, Hartman Grace G., Murase Noriko, Bronsther Oscar, Manez Rafael, Fung John J., Iwatsuki Shunzaburo, Starzl Thomas E., A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies, 10.1002/hep.1840160310
  130. O'Leary Jacqueline G., Michelle Shiller S., Bellamy Christopher, Nalesnik Michael A., Kaneku Hugo, Jennings Linda W., Isse Kumiko, Terasaki Paul I., Klintmalm Göran B., Demetris Anthony J., Acute liver allograft antibody-mediated rejection: An inter-institutional study of significant histopathological features : Acute Amr Score, 10.1002/lt.23948
  131. Musat A. I., Agni R. M., Wai P. Y., Pirsch J. D., Lorentzen D. F., Powell A., Leverson G. E., Bellingham J. M., Fernandez L. A., Foley D. P., Mezrich J. D., D’Alessandro A. M., Lucey M. R., The Significance of Donor-Specific HLA Antibodies in Rejection and Ductopenia Development in ABO Compatible Liver Transplantation : HLA Alloantibodies in Liver Allograft Rejection, 10.1111/j.1600-6143.2010.03414.x
  132. Lunz J., Ruppert K. M., Cajaiba M. M., Isse K., Bentlejewski C. A., Minervini M., Nalesnik M. A., Randhawa P., Rubin E., Sasatomi E., Vera M. E. de, Fontes P., Humar A., Zeevi A., Demetris A. J., Re-examination of the Lymphocytotoxic Crossmatch in Liver Transplantation: Can C4d Stains Help in Monitoring? : Positive Crossmatch and C4d in Liver Transplantation, 10.1111/j.1600-6143.2011.03786.x
  133. Salah Adeeb, Fujimoto Masakazu, Yoshizawa Atsushi, Yurugi Kimiko, Miyagawa-Hayashino Aya, Sumiyoshi Shinji, Minamiguchi Sachiko, Uemoto Shinji, Maekawa Taira, Haga Hironori, Application of complement component 4d immunohistochemistry to ABO-compatible and ABO-incompatible liver transplantation : C4dImmunohistochemistry in Liver Allografts, 10.1002/lt.23789
  134. O'Leary Jacqueline G., Kaneku Hugo, Demetris Anthony J., Marr John D., Shiller S. Michelle, Susskind Brian M., Tillery Glenn W., Terasaki Paul I., Klintmalm Göran B., Antibody-mediated rejection as a contributor to previously unexplained early liver allograft loss : Antibody-Mediated Liver Transplant Rejection, 10.1002/lt.23788
  135. Martelius Timi, Halme Leena, Arola Johanna, Höckerstedt Krister, Lautenschlager Irmeli, Vascular deposition of complement C4d is increased in liver allografts with chronic rejection, 10.1016/j.trim.2009.06.004
  136. Corrêa Rosana Rosa Miranda, Machado Juliana Reis, da Silva Marcos Vinícius, Helmo Fernanda Rodrigues, Guimarães Camila Souza Oliveira, Rocha Laura Penna, Faleiros Ana Carolina Guimarães, dos Reis Marlene Antônia, The Importance of C4d in Biopsies of Kidney Transplant Recipients, 10.1155/2013/678180
  137. Cornell Lynn D., Renal allograft pathology in the sensitized patient : , 10.1097/mot.0b013e3283614c5a
  138. Raut Vikram, Uemoto Shinji, Management of ABO-incompatible living-donor liver transplantation: Past and present trends, 10.1007/s00595-010-4437-3
  139. Haga Hironori, Egawa Hiroto, Shirase Tomoyuki, Miyagawa Aya, Sakurai Takaki, Minamiguchi Sachiko, Yamabe Hirohiko, Manabe Toshiaki, Tanaka Koichi, Periportal edema and necrosis as diagnostic histological features of early humoral rejection in ABO-incompatible liver transplantation, 10.1002/lt.20002
  140. Mañez Rafael, Kelly Robert H., Kobayashi Makoto, Takaya Shunichi, Bronsther Oscar, Kramer David, Duquesnoy Rene J., Iwaki Yuichi, Fung John J., Starzl Thomas E., Demetris Anthony J., Immunoglobulin g lymphocytotoxic antibodies in clinical liver transplantation: Studies toward further defining their significance, 10.1002/hep.1840210519
  141. O’Leary Jacqueline G., Klintmalm Göran B., Impact of donor-specific antibodies on results of liver transplantation : , 10.1097/mot.0b013e3283614a10
  142. Al-Sibae Mohamad R., Koffron Alan J., Raofi Vandad, Does a Positive Pretransplant Crossmatch Affect Long-Term Outcome in Liver Transplantation? : , 10.1097/tp.0b013e318204758c
  143. Chan Kun-Ming, Lee Ching-Sung, Wu Ting-Jung, Lee Chen-Fang, Chen Tse-Ching, Lee Wei-Chen, Clinical Perspective of Acute Humoral Rejection After Blood Type-Compatible Liver Transplantation : , 10.1097/tp.0b013e318208138c
  144. Tambur A. R., Herrera N. D., Haarberg K. M. K., Cusick M. F., Gordon R. A., Leventhal J. R., Friedewald J. J., Glotz D., Assessing Antibody Strength: Comparison of MFI, C1q, and Titer Information : Determining Antibody Strength, 10.1111/ajt.13295
  145. Starzl, Clin Transpl, 3, 37 (1989)
  146. Hori Tomohide, Egawa Hiroto, Takada Yasutsugu, Oike Fumitaka, Ogura Yasuhiro, Ogawa Kohei, Kaido Toshimi, Toshimitsu Yasuko, Yagi Shintaro, Iida Taku, Nguyen Justin H., Uemoto Shinji, Fatal impact of lymphocyte cross-matching upon humoral rejection after adult living related liver transplantation, 10.1111/j.1432-2277.2009.00954.x
  147. Fung, Transpl Proc, 19, 767 (1987)
  148. O'Leary J. G., Gebel H. M., Ruiz R., Bray R. A., Marr J. D., Zhou X. J., Shiller S. M., Susskind B. M., Kirk A. D., Klintmalm G. B., Class II Alloantibody and Mortality in Simultaneous Liver-Kidney Transplantation : Class II DSA in SLKT, 10.1111/ajt.12147
  149. Del Bello A., Congy-Jolivet N., Muscari F., Lavayssière L., Esposito L., Cardeau-Desangles I., Guitard J., Dörr G., Suc B., Duffas J. P., Alric L., Bureau C., Danjoux M., Guilbeau-Frugier C., Blancher A., Rostaing L., Kamar N., Prevalence, Incidence and Risk Factors for Donor-Specific Anti-HLA Antibodies in Maintenance Liver Transplant Patients : DSA Maintenance After Liver Transplantation, 10.1111/ajt.12651
  150. Colvin R. B., Dimensions of Antibody-Mediated Rejection : Editorial, 10.1111/j.1600-6143.2010.03172.x
  151. Colvin R. B., Antibody-Mediated Renal Allograft Rejection: Diagnosis and Pathogenesis, 10.1681/asn.2007010073
  152. Martin T., Schwartz J., Demetris A., Comstock J., Lowichik A., Book L., Plasmapheresis treatment of antibody-mediated rejection in an A2 donor to O pediatric liver transplant recipient : Plasmapheresis treatment of antibody-mediated rejection, 10.1111/j.1399-3046.2009.01224.x
  153. Egawa Hiroto, Uemoto Shinji, Inomata Yukihiro, Shapiro A.M.James, Asonuma Katsuhiro, Kiuchi Tetsuya, Okajima Hideaki, Itou Kyo, Tanaka Koichi, Biliary complications in pediatric living related liver transplantation, 10.1016/s0039-6060(98)70015-7
  154. Sebagh Mylène, Farges Oliver, Kalil Antonio, Samuel Didier, Bismuth Henri, Reynes Michel, Sclerosing Cholangitis Following Human Orthotopic Liver Transplantation : , 10.1097/00000478-199501000-00010
  155. Kakizoe Saburo, Yanaga Katsuhiko, Starzl Thomas E., Demetris A. Jake, Evaluation of protocol before transplantation and after reperfusion biopsies from human orthotopic liver allografts: Considerations of preservation and early immunological injury, 10.1002/hep.1840110605
  156. Watson R., Kozlowski T., Nickeleit V., Woosley J. T., Schmitz J. L., Zacks S. L., Fair J. H., Gerber D. A., Andreoni K. A., Isolated Donor Specific Alloantibody-Mediated Rejection after ABO Compatible Liver Transplantation, 10.1111/j.1600-6143.2006.01554.x
  157. Iacob Speranta, Cicinnati Vito R., Dechêne Alexander, Lindemann Monika, Heinemann Falko M., Rebmann Vera, Ferencik Stanislav, Sotiropoulos Georgios C., Popescu Irinel, Horn Peter A., Gerken Guido, Paul Andreas, Beckebaum Susanne, Genetic, immunological and clinical risk factors for biliary strictures following liver transplantation, 10.1111/j.1478-3231.2012.02810.x
  158. Song Seung Hwan, Kim Myoung Soo, Lee Jung Jun, Ju Man Ki, Lee Jae Geun, Lee Juhan, Choi Jin Sub, Choi Gi Hong, Kim Soon Il, Joo Dong Jin, Effect of donor-specific antibodies and panel reactive antibodies in living donor liver transplant recipients, 10.4174/astr.2015.88.2.100
  159. Rostron Anthony, Carter Vaughan, Mutunga Mbithe, Cavanagh Gary, O'Suilleabhain Criostoir, Burt Alistair, Jaques Bryon, Talbot David, Manas Derek, A case of acute humoral rejection in liver transplantation: successful treatment with plasmapheresis and mycophenolate mofetil, 10.1111/j.1432-2277.2005.00200.x
  160. Aoki Taku, Sugawara Yasuhiko, Takahashi Michiro, Kawaguchi Yoshikuni, Kaneko Junichi, Yamashiki Noriyo, Tamura Sumihito, Hasegawa Kiyoshi, Takahashi Kouki, Kokudo Norihiro, Living donor liver transplantation using sensitized lymphocytotoxic crossmatch positive graft, 10.1007/s00535-012-0530-2
  161. Kheradmand T., Anthony T.L., Harland R.C., Testa G., Hart J., Renz J., Te H.S., Marino S.R., Antibody-mediated rejection in ABO compatible husband to wife living donor liver transplant and review of the literature, 10.1016/j.humimm.2014.02.010
  162. Kozlowski Tomasz, Andreoni Kenneth, Schmitz John, Hideo Hayashi Paul, Nickeleit Volker, Sinusoidal C4d deposits in liver allografts indicate an antibody-mediated response: Diagnostic considerations in the evaluation of liver allografts, 10.1002/lt.23403
  163. Kaneku H., O'Leary J. G., Banuelos N., Jennings L. W., Susskind B. M., Klintmalm G. B., Terasaki P. I., De NovoDonor-Specific HLA Antibodies Decrease Patient and Graft Survival in Liver Transplant Recipients : De NovoDSA in Liver Transplantation, 10.1111/ajt.12212
  164. Kaneku Hugo, O'Leary Jacqueline G., Taniguchi Michiko, Susskind Brian M., Terasaki Paul I., Klintmalm Göran B., Donor-specific human leukocyte antigen antibodies of the immunoglobulin G3 subclass are associated with Chronic rejection and graft loss after liver transplantation, 10.1002/lt.23451
  165. O'Leary J. G., Kaneku H., Banuelos N., Jennings L. W., Klintmalm G. B., Terasaki P. I., Impact of IgG3 Subclass and C1q-Fixing Donor-Specific HLA Alloantibodies on Rejection and Survival in Liver Transplantation : IgG3 and C1q-Fixing DSA in Liver Transplantation, 10.1111/ajt.13153
  166. Feng Sandy, Demetris Anthony J., Spain Katharine M., Kanaparthi Sai, Burrell Bryna E., Ekong Udeme D., Alonso Estella M., Rosenthal Philip, Turka Laurence A., Ikle David, Tchao Nadia K., Five-year histological and serological follow-up of operationally tolerant pediatric liver transplant recipients enrolled in WISP-R : Hepatology, Vol. XX, No. X, 2016 Feng et al., 10.1002/hep.28681
  167. Miyagawa-Hayashino Aya, Yoshizawa Atushi, Uchida Yoichiro, Egawa Hiroto, Yurugi Kimiko, Masuda Satohiro, Minamiguchi Sachiko, Maekawa Taira, Uemoto Shinji, Haga Hironori, Progressive graft fibrosis and donor-specific human leukocyte antigen antibodies in pediatric late liver allografts, 10.1002/lt.23534
  168. Iacob Speranta, Cicinnati Vito R., Lindemann Monika, Heinemann Falko M., Radtke Arnold, Kaiser Gernot M., Kabar Iyad, Schmidt Hartmut H. J., Baba Hideo A., Beckebaum Susanne, Donor-Specific Anti-HLA Antibodies and Endothelial C4d Deposition—Association With Chronic Liver Allograft Failure : , 10.1097/tp.0000000000000613
  169. Feng Sandy, Ekong Udeme D., Lobritto Steven J., Demetris Anthony J., Roberts John P., Rosenthal Philip, Alonso Estella M., Philogene Mary C., Ikle David, Poole Katharine M., Bridges Nancy D., Turka Laurence A., Tchao Nadia K., Complete Immunosuppression Withdrawal and Subsequent Allograft Function Among Pediatric Recipients of Parental Living Donor Liver Transplants, 10.1001/jama.2011.2014
  170. Solez K., Colvin R. B., Racusen L. C., Sis B., Halloran P. F., Birk P. E., Campbell P. M., Cascalho M., Collins A. B., Demetris A. J., Drachenberg C. B., Gibson I. W., Grimm P. C., Haas M., Lerut E., Liapis H., Mannon R. B., Marcus P. B., Mengel M., Mihatsch M. J., Nankivell B. J., Nickeleit V., Papadimitriou J. C., Platt J. L., Randhawa P., Roberts I., Salinas-Madriga L., Salomon D. R., Seron D., Sheaff M., Weening J. J., Banff '05 Meeting Report: Differential Diagnosis of Chronic Allograft Injury and Elimination of Chronic Allograft Nephropathy (?CAN?), 10.1111/j.1600-6143.2006.01688.x
  171. Shimizu A., Ishii E., Kuwahara N., Arai T., Kanzaki G., Higo S., Kajimoto Y., Nagasaka S., Masuda Y., Fukuda Y., Chronic Antibody-Mediated Responses May Mediate Chronic Rejection in Rat Orthotopic Liver Transplantation, 10.1016/j.transproceed.2013.02.045
  172. Wan R., Ying W., Zeng L., Deng X., Chen H., Gao L., Antibody-Mediated Response in Rat Liver Chronic Rejection, 10.1016/j.transproceed.2011.03.043
  173. Donaldson P.T., O'Grady J., Portmann B., Davis H., Alexander G.J.M., Neuberger J., Thick M., Calne R.Y., Williams Roger, EVIDENCE FOR AN IMMUNE RESPONSE TO HLA CLASS I ANTIGENS IN THE VANISHING-BILEDUCT SYNDROME AFTER LIVER TRANSPLANTATION, 10.1016/s0140-6736(87)90293-5
  174. MATSUMOTO YORIO, MCCAUGHAN GEOFFREY W., PAINTER DOROTHY M., BISHOP G. ALEX, EVIDENCE THAT PORTAL TRACT MICROVASCULAR DESTRUCTION PRECEDES BILE DUCT LOSS IN HUMAN LIVER ALLOGRAFT REJECTION : , 10.1097/00007890-199307000-00012
  175. DONALDSON PETER T., THOMSON LINDA J., HEADS ALASDAIR, UNDERBILL JAMES A., VAUGHAN ROBERT W., ROLANDO NANCY, WILLIAMS ROGER, IgG DONOR-SPECIFIC CROSSMATCHES ARE NOT ASSOCIATED WITH GRAFT REJECTION OR POOR GRAFT SURVIVAL AFTER LIVER TRANSPLANTATION : AN ASSESSMENT BY CYTOTOXICITY AND FLOW CYTOMETRY, 10.1097/00007890-199511150-00024
  176. Grabhorn Enke, Binder Thomas M. C., Obrecht Denise, Brinkert Florian, Lehnhardt Anja, Herden Uta, Peine Sven, Nashan Björn, Ganschow Rainer, Briem-Richter Andrea, Long-term Clinical Relevance of De Novo Donor-Specific Antibodies After Pediatric Liver Transplantation : , 10.1097/tp.0000000000000638
  177. Kurowski Przemysław N., Immunological Factors and Liver Fibrosis in Pediatric Liver Transplant Recipients, 10.12659/aot.892544
  178. Batts Kenneth P., Moore S. Breanndan, Perkins James D., Wiesner Russell H., Grambsch Patricia M., Krom Ruud A. F., INFLUENCE OF POSITIVE LYMPHOCYTE CROSSMATCH AND HLA MISMATCHING ON VANISHING BILE DUCT SYNDROME IN HUMAN LIVER ALLOGRAFTS : , 10.1097/00007890-198802000-00026
  179. Kosola Silja, Lampela Hanna, Jalanko Hannu, Mäkisalo Heikki, Lohi Jouko, Arola Johanna, Pakarinen Mikko P., Low-dose steroids associated with milder histological changes after pediatric liver transplantation : Low-Dose Steroids, 10.1002/lt.23565
  180. Yoshitomi Mami, Koshiba Takaaki, Haga Hironori, Li Ying, Zhao Xiangdong, Cheng Donghua, Miyagawa Aya, Sakashita Hiromi, Tsuruyama Tatsuaki, Ohe Hidenori, Ueda Mikiko, Okamoto Shinya, Egawa Hiroto, Wood Kathryn, Sakaguchi Shimon, Manabe Toshiaki, Tanaka Koichi, Uemoto Shinji, Requirement of Protocol Biopsy Before and After Complete Cessation of Immunosuppression After Liver Transplantation : , 10.1097/tp.0b013e318195a7cb
  181. Koshiba Takaaki, Li Ying, Takemura Mami, Wu Yanling, Sakaguchi Shimon, Minato Nagahiro, Wood Kathryn J., Haga Hironori, Ueda Mikiko, Uemoto Shinji, Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation, 10.1016/j.trim.2006.10.004
  182. Mauiyyedi, J Am Soc Nephrol, 12, 574 (2001)
  183. Hoshino Junichi, Kaneku Hugo, Everly Matthew J., Greenland Sander, Terasaki Paul I., Using Donor-Specific Antibodies to Monitor the Need for Immunosuppression : , 10.1097/tp.0b013e31824f3d7c
  184. Demetris Anthony J., Lunz III John G., Randhawa Parmjeet, Wu Tong, Nalesnik Michael, Thomson Angus W., Monitoring of human liver and kidney allograft tolerance: a tissue/histopathology perspective, 10.1111/j.1432-2277.2008.00765.x
  185. Benítez Carlos, Londoño María-Carlota, Miquel Rosa, Manzia Tommaso-Maria, Abraldes Juan G., Lozano Juan-José, Martínez-Llordella Marc, López Marta, Angelico Roberta, Bohne Felix, Sese Pilar, Daoud Frederic, Larcier Patrick, Roelen Dave L., Claas Frans, Whitehouse Gavin, Lerut Jan, Pirenne Jacques, Rimola Antoni, Tisone Giuseppe, Sánchez-Fueyo Alberto, Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients : Hepatology, 10.1002/hep.26426
  186. Egawa Hiroto, Miyagawa-Hayashino Aya, Haga Hironori, Teramukai Satoshi, Yoshizawa Atsushi, Ogawa Kohei, Ogura Yasuhiro, Okamoto Shinya, Kaido Toshimi, Uemoto Shinji, Non-inflammatory centrilobular sinusoidal fibrosis in pediatric liver transplant recipients under tacrolimus withdrawal : Centrilobular fibrosis after liver transplantation, 10.1111/j.1872-034x.2012.01003.x
  187. Li Yan, Lu Lina, Qian Shiguang, Fung John J., Lin Feng, Hepatic Stellate Cells Directly Inhibit B Cells via Programmed Death–Ligand 1, 10.4049/jimmunol.1501737
  188. Song G.-W., Lee S.-G., Hwang S., Kim K.-H., Ahn C.-S., Moon D.-B., Ha T.-Y., Jung D.-H., Park G.-C., Kim W.-J., Sin M.-H., Yoon Y.-I., Kang W.-H., Kim S.-H., Tak E.-Y., ABO-Incompatible Adult Living Donor Liver Transplantation Under the Desensitization Protocol With Rituximab : ABOi ALDLT, 10.1111/ajt.13444
  189. Kim Peter T.W., Demetris Anthony J., O’Leary Jacqueline G., Prevention and treatment of liver allograft antibody-mediated rejection and the role of the ‘two-hit hypothesis’ : , 10.1097/mot.0000000000000275
  190. Musat, Liver Transpl, 19, 1132 (2013)
  191. Castillo-Rama Marcela, Castro Maria Jose, Bernardo Ivan, Meneu-Diaz Juan Carlos, Moreno Elola-Olaso Almudena, Calleja-Antolin Sara M., Romo Eva, Morales Pablo, Moreno Enrique, Paz-Artal Estela, Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: Role of human leukocyte antigen compatibility, 10.1002/lt.21408
  192. Paterno F., Shiller M., Tillery G., O’Leary J. G., Susskind B., Trotter J., Klintmalm G. B., Bortezomib for Acute Antibody-Mediated Rejection in Liver Transplantation : Bortezomib for Acute Antibody-Mediated Rejection, 10.1111/j.1600-6143.2012.04126.x
  193. Kamar Nassim, Lavayssière Laurence, Muscari Fabrice, Selves Janick, Guilbeau-Frugier Céline, Cardeau Isabelle, Esposito Laure, Cointault Olivier, Nogier Marie Béatrice, Peron Jean Marie, Otal Philippe, Fort Marylise, Rostaing Lionel, Early plasmapheresis and rituximab for acute humoral rejection after ABO-compatible liver transplantation, 10.3748/wjg.15.3426
  194. Schadde, Clin Transpl, 479 (2006)
  195. Wilson Colin H., Agarwal Kosh, Talbot David, Jaques Brian C., Manas Derek M., Carter Vaughan, Burt Alastair D., H??bscher Stefan, Late Humoral Rejection in a Compliant ABO-compatible Liver Transplant Recipient : , 10.1097/01.tp.0000229939.85412.27
  196. Del Bello Arnaud, Congy-Jolivet Nicolas, Danjoux Marie, Muscari Fabrice, Lavayssière Laurence, Esposito Laure, Cardeau-Desangles Isabelle, Guitard Joëlle, Dörr Gaëlle, Milongo David, Suc Bertrand, Duffas Jean Pierre, Alric Laurent, Bureau Christophe, Guilbeau-Frugier Céline, Rostaing Lionel, Kamar Nassim, De novodonor-specific anti-HLA antibodies mediated rejection in liver-transplant patients, 10.1111/tri.12654
  197. OʼLeary Jacqueline G., Samaniego Millie, Barrio Marta Crespo, Potena Luciano, Zeevi Adriana, Djamali Arjang, Cozzi Emanuele, The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients : , 10.1097/tp.0000000000000869
  198. Wong Terence, Nouri-Aria Kayhan T., Devlin John, Portmann Bernard, Williams Roger, Tolerance and latent cellular rejection in long-term liver transplant recipients, 10.1002/hep.510280223
  199. Feng, Am J Transplant, 15 (2015)
  200. Bohne Felix, Martínez-Llordella Marc, Lozano Juan-José, Miquel Rosa, Benítez Carlos, Londoño María-Carlota, Manzia Tommaso-María, Angelico Roberta, Swinkels Dorine W., Tjalsma Harold, López Marta, Abraldes Juan G., Bonaccorsi-Riani Eliano, Jaeckel Elmar, Taubert Richard, Pirenne Jacques, Rimola Antoni, Tisone Giuseppe, Sánchez-Fueyo Alberto, Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation, 10.1172/jci59411
  201. Taubert R., Danger R., Londoño M.-C., Christakoudi S., Martinez-Picola M., Rimola A., Manns M. P., Sánchez-Fueyo A., Jaeckel E., Hepatic Infiltrates in Operational Tolerant Patients After Liver Transplantation Show Enrichment of Regulatory T Cells Before Proinflammatory Genes Are Downregulated, 10.1111/ajt.13617
  202. Dragun Duska, Catar Rusan, Philippe Aurélie, Non-HLA antibodies in solid organ transplantation : recent concepts and clinical relevance, 10.1097/mot.0b013e3283636e55
  203. Akiyoshi Takurin, Hirohashi Tsutomu, Alessandrini Alessandro, Chase Catherine M., Farkash Evan A., Neal Smith R., Madsen Joren C., Russell Paul S., Colvin Robert B., Role of complement and NK cells in antibody mediated rejection, 10.1016/j.humimm.2012.07.330
  204. Sellarés J., Reeve J., Loupy A., Mengel M., Sis B., Skene A., de Freitas D. G., Kreepala C., Hidalgo L. G., Famulski K. S., Halloran P. F., Molecular Diagnosis of Antibody-Mediated Rejection in Human Kidney Transplants : Molecular Diagnosis of ABMR, 10.1111/ajt.12150
  205. Wu K. Y., Budde K., Schmidt D., Neumayer H. H., Rudolph B., Acute cellular rejection with isolated v-lesions is not associated with more favorable outcomes than vascular rejection with more tubulointerstitial inflammations, 10.1111/ctr.12333